Cargando…

Antifibrinolytic agents and angiotensin-converting enzyme inhibitors: the effect on postoperative renal dysfunction in cardiac surgery

Detalles Bibliográficos
Autores principales:	Mouton, R, Binks, A, Davies, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095445/ http://dx.doi.org/10.1186/cc5552

Ejemplares similares

Preoperative therapy with angiotensin-converting enzyme inhibitors in cardiac surgery patients: is there any impact on postoperative renal function?
por: Ampatzidou, F, et al.
Publicado: (2014)

Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells
por: Wojewodzka-Zelezniakowicz, Marzena, et al.
Publicado: (2017)

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
por: Makdisse, MRP, et al.
Publicado: (2007)

Angiotensin converting enzymes in patients with acute respiratory distress syndrome
por: Annoni, F, et al.
Publicado: (2015)

Secondary prevention following surgical revascularisation: continuing under-use of angiotensin-converting enzyme inhibitors
por: Turley, A, et al.
Publicado: (2007)

Relationship between angiotensin-converting enzyme gene polymorphism (insertion/deletion) and the clinical condition of sepsis
por: Yildizdas, R
Publicado: (2008)

Antifibrinolytic Agents in Traumatic Haemorrhage
por: Coats, Tim, et al.
Publicado: (2005)

Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009)

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
por: Kazakov, Rossen M, et al.
Publicado: (2015)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Antifibrinolytics
por: Székely, A, et al.
Publicado: (2014)

Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiac magnetic resonance imaging
por: Williams, Katelyn, et al.
Publicado: (2011)

Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
por: Tsangaris, I, et al.
Publicado: (2011)

Effect of angiotensin-converting enzyme gene I/D polymorphism and its expression on clinical outcome in acute respiratory distress syndrome
por: Tsangaris, I, et al.
Publicado: (2013)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
por: Bisinotto, Flora Margarida Barra, et al.
Publicado: (2019)

Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice
por: Ito, Aiko, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with cardiovascular death, postoperative cardiac, renal and pulmonary dysfunction
por: Hajjar, L, et al.
Publicado: (2008)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Antifibrinolytics and Cardiac Surgery: The Past, The Present, and The Future
por: Aggarwal, Naresh K, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Resistive index as a predictor of renal progression in patients with moderate renal dysfunction regardless of angiotensin converting enzyme inhibitor or angiotensin receptor antagonist medication
por: Kim, Jae Hoon, et al.
Publicado: (2017)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Time to switch angiotensin-converting enzyme inhibitors/angiotensin receptor blockers to sacubitril/valsartan in patients with cancer therapy-related cardiac dysfunction
por: Xi, Qianlan, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
por: Brown, Sherry‐Ann, et al.
Publicado: (2020)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Infection rates among cooled patients post cardiac arrest
por: Binks, A, et al.
Publicado: (2010)

Antifibrinolytics in liver surgery
por: Makwana, Jalpa, et al.
Publicado: (2010)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

The Safety and Efficacy of Antifibrinolytic Therapy in Neonatal Cardiac Surgery
por: Lin, Chih-Yuan, et al.
Publicado: (2015)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain
por: Hernández, Ángel Alonso, et al.
Publicado: (2010)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
por: Khattak, Z., et al.
Publicado: (2021)

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Have No Significant Relationship With Postoperative Arthrofibrosis After Shoulder Arthroscopy
por: Bi, Andrew S., et al.
Publicado: (2023)

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease
por: Lebek, Simon, et al.
Publicado: (2020)

Propofol is the induction agent of choice for urgent intubations with UK physicians
por: Rooney, KD, et al.
Publicado: (2011)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sc1aqhu7egbfvcilip1e12ae28